Diagnostik und Therapie der Keratomykose

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Der Ophthalmologe

• Publication date

  2009-05-09

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s00347-009-1925-1PMID 19424703
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aqueous Humor Concentrations of Topically Administered Caspofungin in Rabbits

  2008cited by this paper
• Posaconazole in intensive care patients I: invasive fungal infections in surgical intensive care and case presentation

  2008cited by this paper
• Temperature instability of ReNu With MoistureLoc: a new theory to explain the worldwide Fusarium keratitis epidemic of 2004-2006.

  2008cited by this paper
• An outbreak of fusarium keratitis associated with contact lens use in the northeastern United States.

  2008cited by this paper
• Posaconazole for paediatric patients: status of development and future perspectives

  2008cited by this paper
• Aqueous humor concentration of voriconazole after topical administration in rabbits

  2008cited by this paper
• Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.

  2007cited by this paper
• [Therapy and prognosis of bacterial keratitis].

  2007cited by this paper
• [Bacterial keratitis. Current diagnostic aspects].

  2007cited by this paper
• Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

  2007cited by this paper
• Bakterielle Keratitis – aktuelle Aspekte zur Diagnostik

  2006cited by this paper
• [Diagnostics of fungal infections of the eye and of its adnexa].

  2006cited by this paper
• Therapie und Prognose der bakteriellen Keratitis

  2006cited by this paper
• Diagnostik von Mykosen des Auges und seiner Adnexe

  2006cited by this paper
• In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts

  2006cited by this paper
• Antiinfektive medikamentöse Therapie am Auge - Teil 3: Mykotische Infektionen

  2005cited by this paper
• Utility of Random Amplification of Polymorphic DNA Assay and BOX-A PCR in Molecular Characterization of Streptococcus pneumoniae Isolates Recovered from Various Ophthalmic Infections

  2005cited by this paper
• Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin.

  2005cited by this paper
• Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.

  2005cited by this paper
• [Anti-infective therapy of the eye -- part 3: mycotic infections].

  2005cited by this paper
• Fungal keratitis

  2004cited by this paper
• Voriconazole in Fungal Keratitis Caused by Scedosporium apiospermum

  2004cited by this paper
• Effect of voriconazole on a corneal abscess caused by fusarium.

  2004cited by this paper
• Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans.

  2004cited by this paper
• Intravitreal voriconazole: an electroretinographic and histopathologic study.

  2004cited by this paper
• In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.

  2004cited by this paper
• Voriconazole in fungal keratitis caused by Scedosporium apiospermum.

  2004cited by this paper
• Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.

  2003cited by this paper
• Candida Parapsilosis Keratitis

  2003cited by this paper
• A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

  2003cited by this paper
• Echinocandin antifungal drugs.

  2003cited by this paper
• Fluconazole plus amphotericin B combinations are not contraindicated and may add benefit for the treatment of candidemia.

  2003cited by this paper
• Fungal infections of the cornea

  2003cited by this paper
• Bilateral Candida parapsilosis interface keratitis after laser in situ keratomileusis.

  2003cited by this paper
• Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.

  2002cited by this paper
• Safety and Pharmacokinetics of Oral Voriconazole in Patients at Risk of Fungal Infection: A Dose Escalation Study

  2002cited by this paper
• Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

  2002cited by this paper
• Topical Cyclosporin A in the Management of Therapeutic Keratoplasty for Mycotic Keratitis

  2002cited by this paper
• Severe Keratomycosis Secondary to Scedosporium Apiospermum

  2002cited by this paper
• Pharmacokinetics and Safety of Voriconazole following Intravenous- to Oral-Dose Escalation Regimens

  2002cited by this paper
• The safety of voriconazole.

  2002cited by this paper
• Voriconazole and fluconazole susceptibility of Candida isolates.

  2002cited by this paper
• In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida spp

  2002cited by this paper
• Review of the safety and efficacy of voriconazole

  2002cited by this paper
• Determination of voriconazole in aqueous humor by liquid chromatography-electrospray ionization-mass spectrometry.

  2002cited by this paper
• A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.

  2001cited by this paper
• In Vitro Fungicidal Activities of Voriconazole, Itraconazole, and Amphotericin B against Opportunistic Moniliaceous and Dematiaceous Fungi

  2001cited by this paper
• [Polymerase chain reaction (PCR) for microbiological diagnosis in refractory infectious keratitis: a clinical study in 16 patients].

  2000cited by this paper
• Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole

  2000cited by this paper
• An Overview of Fungal Pathogens of Ophthalmological Importance

  1999cited by this paper
• Mycosis of the eye and its adnexa.

  1999cited by this paper
• Candida glabrata endophthalmitis following penetrating keratoplasty

  1998cited by this paper
• Large-scale multicentre study of fluconazole in the treatment of hospitalised patients with fungal infections

  1997cited by this paper
• International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.

  1997cited by this paper
• [Fluconazole level in aqueous humor after oral drug administration in humans].

  1995cited by this paper
• The changing spectrum of fungal keratitis in south Florida.

  1994cited by this paper
• Treatment of multiple corneal abscesses with fluconazole.

  1994cited by this paper
• Fluconazole in the treatment of candida albicans endophthalmitis

  1992cited by this paper
• Pilzerkrankungen des Auges

  1991cited by this paper
• Candida tropicalis endophthalmitis following penetrating keratoplasty.

  1991cited by this paper
• Influence of corticosteroid on experimentally induced keratomycosis.

  1991cited by this paper
• Natamycin (Pimaricin) in der Behandlung der experimentellen Keratomykose

  1990cited by this paper
• [Natamycin (pimaricin) in the treatment of experimental keratomycosis].

  1990cited by this paper
• Topical fluconazole for experimental candida keratitis in rabbits.

  1990cited by this paper
• Pharmacologic management of keratomycoses.

  1988cited by this paper
• Exogenous fungal endophthalmitis.

  1988cited by this paper
• [Effect of corticosteroids in antimycotic therapy of Candida keratitis].

  1987cited by this paper
• [Experimental studies of local therapy of Candida keratomycosis with amphotericin B].

  1987cited by this paper
• Der Einfluß von Kortikosteroiden bei der antimykotischen Therapie der Candida-Keratitis

  1987cited by this paper
• Amphotericin clearance in vitrectomized versus nonvitrectomized eyes.

  1985cited by this paper
• Successful treatment of Candida albicans endophthalmitis with intravitreal amphotericin B.

  1981cited by this paper
• POSTOPERATIVE ENDOPHTHALMITIS SECONDARY TO CANDIDA PARAPSILOSIS: A Case Treated by Vitrectomy and Intravitreous Therapy

  1981cited by this paper
• Fusarium oxysporum endophthalmitis.

  1979cited by this paper
• [Fungal growth on soft contact lenses (author's transl)].

  1978cited by this paper
• Intravitreal amphotericin B treatment of Candida endophthamitis.

  1977cited by this paper
• Permeability of the cornea to topically applied drugs.

  1974cited by this paper
• Corticosteroids and ocular mycoses: experimental study.

  1974cited by this paper
• Production of corneal ulcer by opportunistic and saprophytic fungi. 1. The effect of pretreatment of fungi with steroid.

  1973cited by this paper
• Subconjunctival nodules after amphotericin B injection. Medical therapy for Aspergillus corneal ulcer.

  1973cited by this paper
• Production of corneal ulcer by opportunistic and saprophytic fungi. 1. The effect of pretreatment of fungi with steroid.

  1973cited by this paper
• Keratomycosis. Medical and surgical treatment.

  1971cited by this paper
• Combined pimaricin and dexamethasone therapy of keratomycosis.

  1971cited by this paper
• Deep fungal corneal abscess. Combined corticosteroid therapy.

  1971cited by this paper
• Pimaricin therapy of cephalosporium and fusarium keratitis.

  1970cited by this paper
• Mycotic Keratitis* *From the Division of Ophthalmology, College of Medicine, University of Florida. This work was supported in part by U.S.P.H.S. grants No. NB-04978 and NB-04977 from the National Institute of Neurological Diseases and Blindness.

  1965cited by this paper
• MYCOTIC KERATITIS.

  1965cited by this paper
• Untersuchungen zum Einfluß des Cortisons auf die experimentelle Candidamykose der Kaninchenhornhaut

  1963cited by this paper
• [ON THE EFFECT OF CORTISONE ON THE PATHOGENESIS OF KERATOMYCOSIS OF THE RABBIT EYE CAUSED BY SAPHROPHYTIC FUNGI OF THE HUMAN CONJUNCTIVAL SAC].

  1963cited by this paper
• The influence of cortisone on experimental fungus infections in mice.

  1960cited by this paper
• Mycotic ulcerative keratitis.

  1959cited by this paper
• Mycotic Keratitis

  1958cited by this paper
• Nystatin in monilia keratoconjunctivitis; a case report.

  1957cited by this paper
• The permeability of the cornea.

  1953cited by this paper

• Fungal keratitis in Germany : Diagnostics, conservative and microsurgical treatment.

  2026cites this paper
• Pilzkeratitis in Deutschland

  2025cites this paper
• Treatment Strategies for Filamentous Fungi Keratitis

  2024cites this paper
• Erste Fallbeschreibung einer Eutypella-scoparia-Keratitis

  2024cites this paper
• Hypopyon: Is-it Infective or Noninfective?

  2021cites this paper
• Zentrale Sklerokorneoplastik à chaud bei bakteriell superinfizierter, konfokalmikroskopisch gesicherter mykotischer Keratitis auf dem Boden einer rezidivierenden herpetischen Keratitis

  2021cites this paper
• A Rare Case of Rhizopus Oryzae Keratitis following Orbital Cellulitis in a Diabetic Patient

  2021cites this paper
• [Coinfections in contact lens-associated mycotic keratitis with Pseudomonas or Acanthamoeba].

  2020cites this paper
• Mischinfektionen bei kontaktlinsenassoziierter mykotischer Keratitis mit Pseudomonas oder Akanthamöben

  2020cites this paper
• Invertierte in vitro konfokale Mikroskopie bei mykotischer Keratitis mit Hornhaut-Endothel-Epithel-Dekompensation

  2019cites this paper
• Medical and surgical lessons learned from a severe case of Fusarium solani keratitis

  2018cites this paper
• Therapieresistente Fusarienkeratitis mit intraokularer Beteiligung – potenzielle Quellen für eine persistierende Infektion

  2018cites this paper
• Konfokale Mikroskopie zur Diagnostik der mykotischen Keratitis

  2016cites this paper
• Prolongierte topische Natamycin 5 %-Therapie vor und nach Keratoplastik bei Fusarium-Keratitis

  2016cites this paper
• Kortikosteroide als Additiv zur antimikrobiellen Therapie

  2016cites this paper
• [Adjunctive corticosteroids for antimicrobial treatment].

  2016cites this paper
• Das Deutsche Akanthamöbenkeratitis-Register

  2015cites this paper
• [Keratomycosis - Therapy Standards and New Developments].

  2015cites this paper
• Keratomykose – Therapiestandards und aktuelle Entwicklungen

  2015cites this paper
• Untersuchung der Biokompatibilität von Voriconazol (Vfend) auf humane korneale Epithelzellen

  2015cites this paper
• Keratomykose – Therapiestandards und aktuelle Entwicklungen Keratomycosis – Therapy Standards and New Developments

  2015cites this paper
• Erfolgreiche Therapie einer Fusarium-assoziierten Keratitis bei multiresistentem Erreger und multimorbidem Patienten

  2013cites this paper
• Unklarer Iristumor

  2013cites this paper
• [Morphofunctional analysis of the efficiency of keratoplasty in the treatment of keratomycosis].

  2012cites this paper
• Centre Hospitalier Universitaire de Grenoble

  2012cites this paper
• Étude de faisabilité de préparations ophtalmiques au Centre Hospitalier Universitaire de Grenoble

  2012cites this paper
• Morphofunktionelle Untersuchungen der Wirksamkeit der Keratoplastik bei der Behandlung von Keratomykosen

  2012cites this paper
• Benefit of Polyhexamethylene Biguanide in Fusarium Keratitis

  2012cites this paper
• Persistierende kontaktlinsenassoziierte Keratitis

  2011cites this paper
• The challenge of fungal keratitis

  2011cites this paper
• Herpes-simplex-Keratitis. Ein kurzer Überblick zur aktuellen Therapie

  2010cites this paper
• [Herpes simplex keratitis. A short overview of the current therapy].

  2010cites this paper
• Prof. Dr. Wolfgang Behrens-Baumann gewidmet zum 65. Geburtstag

  2010cites this paper
• Rationale Antibiotikatherapie in der Augenheilkunde

  2010cites this paper